Pure Global AI
NCT06364761Not yet recruiting

Assesment of Intermediate Vision After BIL Cataract Surgery

Assesment of Intermediate and Near Vision After Bag in the Lens Cataract Surgery
Universitair Ziekenhuis BrusselClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Cataract
Drug/Device/Intervention
Bag in the lens cataract surgery
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Universitair Ziekenhuis Brussel
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Dec 01, 2024
Enrollment
38 participants
Primary outcome

Intermediate vision

Summary

The goal of this observational study is to learn about the intermediate and near vision in
 patiënts who underwent cataract surgery with a specific technique, called bag in the lens.
 
 The main question it aims to answer is whether patiens who underwent this type of cataract
 surgery have better intermediate vision without spectacle correction than patients who
 underwent the classic lens in the bag cataract surgery.
 
 Participants will:
 
 - Have to read with and without spectacle correction at different distances (4 meters, 66
 centimeters, 40 centimeters)
 
 - Have to fill in 2 questionnaires about visual functioning and spectacle independance
 
 Researchers will compare these values to the same values from the standard population who
 underwent the classic lens in the bag cataract surgery with a monofocal intraocular lens .

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06364761
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06364761 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitair Ziekenhuis Brussel and is currently Not yet recruiting. The study focuses on Cataract. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.